LIVIVO - Search results -

Search results

Result 1 - 8 of total 8

Search options

Article ; Online: Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota

Hai-Yu Zhang / Jia-Xing Tian / Feng-Mei Lian / Min Li / Wen-Ke Liu / Zhong Zhen / Jiang-Quan Liao / Xiao-Lin Tong

Biomedicine & Pharmacotherapy, Vol 133, Iss , Pp 110857- (2021)

2021

Abstract: Metabolic diseases such as obesity, type 2 diabetes mellitus, and hyperlipidemia are associated with the dysfunction of gut microbiota. Traditional Chinese medicines (TCMs) have shown considerable effects in the treatment of metabolic disorders by ... ...

Abstract	Metabolic diseases such as obesity, type 2 diabetes mellitus, and hyperlipidemia are associated with the dysfunction of gut microbiota. Traditional Chinese medicines (TCMs) have shown considerable effects in the treatment of metabolic disorders by regulating the gut microbiota. However, the underlying mechanisms are unclear. Studies have shown that TCMs significantly affect glucose and lipid metabolism by modulating the gut microbiota, particularly mucin-degrading bacteria, bacteria with anti-inflammatory properties, lipopolysaccharide- and short-chain fatty acid (SCFA)-producing bacteria, and bacteria with bile-salt hydrolase activity. In this review, we explored potential mechanisms by which TCM improved metabolic disorders via regulating gut microbiota composition and functional structure. In particular, we focused on the protection of the intestinal barrier function, modulation of metabolic endotoxemia and inflammatory responses, regulation of the effects of SCFAs, modulation of the gut-brain axis, and regulation of bile acid metabolism and tryptophan metabolism as therapeutic mechanisms of TCMs in metabolic diseases.
Keywords	Gut microbiota ; Metabolic disease ; Therapeutic mechanism ; Traditional Chinese medicine ; Therapeutics. Pharmacology ; RM1-950
Subject code	570
Language	English
Publishing date	2021-01-01T00:00:00Z
Publisher	Elsevier
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Utilizing network pharmacology to explore the underlying mechanism of Radix Salviae in diabetic retinopathy

Chun-Li Piao / Jin-Li Luo / De Jin / Cheng Tang / Li Wang / Feng-Mei Lian / Xiao-Lin Tong

Chinese Medicine, Vol 14, Iss 1, Pp 1-

2019 Volume 12

Abstract: Abstract Introduction Radix Salviae (Dan-shen in pinyin), a classic Chinese herb, has been extensively used to treat diabetic retinopathy in clinical practice in China for many years. However, the pharmacological mechanisms of Radix Salviae remain vague. ...

Abstract	Abstract Introduction Radix Salviae (Dan-shen in pinyin), a classic Chinese herb, has been extensively used to treat diabetic retinopathy in clinical practice in China for many years. However, the pharmacological mechanisms of Radix Salviae remain vague. The aim of this study was to decrypt the underlying mechanisms of Radix Salviae in the treatment of diabetic retinopathy using a systems pharmacology approach. Methods A network pharmacology-based strategy was proposed to elucidate the underlying multi-component, multi-target, and multi-pathway mode of action of Radix Salviae against diabetic retinopathy. First, we collected putative targets of Radix Salviae based on the Traditional Chinese Medicine System Pharmacology database and a network of the interactions among the putative targets of Radix Salviae and known therapeutic targets of diabetic retinopathy was built. Then, two topological parameters, “degree” and “closeness certainty” were calculated to identify the major targets in the network. Furthermore, the major hubs were imported to the Database for Annotation, Visualization and Integrated Discovery to perform a pathway enrichment analysis. Results A total of 130 nodes, including 18 putative targets of Radix Salviae, were observed to be major hubs in terms of topological importance. The results of pathway enrichment analysis indicated that putative targets of Radix Salviae mostly participated in various pathways associated with angiogenesis, protein metabolism, inflammatory response, apoptosis, and cell proliferation. The putative targets of Radix Salviae (vascular endothelial growth factor, matrix metalloproteinases, plasminogen, insulin-like growth factor-1, and cyclooxygenase-2) were recognized as active factors involved in the main biological functions of treatment, which implied that these were involved in the underlying mechanisms of Radix Salviae on diabetic retinopathy. Conclusions Radix Salviae could alleviate diabetic retinopathy via the molecular mechanisms predicted by network pharmacology. ...
Keywords	Radix Salviae ; Network pharmacology ; Diabetic retinopathy ; Other systems of medicine ; RZ201-999
Subject code	570
Language	English
Publishing date	2019-12-01T00:00:00Z
Publisher	BMC
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage

De Jin / Wen-Jing Huang / Xiang Meng / Fan Yang / Qi Bao / Mei-zhen Zhang / Ya-nan Yang / Qing Ni / Feng-Mei Lian / Xiao-Lin Tong

Trials, Vol 20, Iss 1, Pp 1-

study protocol for a randomized controlled trial

2019 Volume 8

Abstract: Abstract Background Diabetic kidney disease (DKD) is the main cause of end-stage kidney disease and has become a heavy economic and social burden due to its high prevalence and morbidity. The most effective strategy is that patients with DKD should be ... ...

Abstract	Abstract Background Diabetic kidney disease (DKD) is the main cause of end-stage kidney disease and has become a heavy economic and social burden due to its high prevalence and morbidity. The most effective strategy is that patients with DKD should be diagnosed and treated early. Preliminary studies showed that the Chinese herbal Tangshen Formula (TSF) may delay the progression of DKD, reducing microalbuminuria and macroalbuminuria and improving renal function. We designed a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of TSF in patients with DKD. Methods/design This trial is a 13-center, randomized, double-blind, placebo-controlled study. A total of 632 participants will be randomized in a 1:1 ratio to an experiment group (TSF plus losartan) and a control group (placebo plus losartan). The trial cycle will last 24 weeks. The primary outcome will be the change in the urine microalbumin–creatinine ratio from baseline to week 24. The secondary outcome will be the change in the rate of progression to the clinical proteinuria period after intervention, the rate of urine microalbumin negative conversion, the rate of normal urinary microalbumin, the doubling rate of the baseline creatinine value and the glomerular filtration rate between the two groups. Safety in medication will also be evaluated. Discussion We hypothesize that patients with type 2 diabetes in the early stage of DKD will benefit from TSF. If successful, this study will provide evidence-based recommendations for clinicians. Trial registration ClinicalTrials.gov, NCT03009864. Registered January 2017.
Keywords	Diabetic kidney disease ; Traditional Chinese medicine ; Treatment ; Randomized controlled trial ; Medicine (General) ; R5-920
Subject code	610
Language	English
Publishing date	2019-12-01T00:00:00Z
Publisher	BMC
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Efficacy of Jinhua Qinggan Granules Combined With Western Medicine in the Treatment of Confirmed and Suspected COVID-19

XueDong An / Xi Xu / MingZhong Xiao / XiaoJun Min / Yi Lyu / JiaXing Tian / Jia Ke / SuPing Lang / Qing Zhang / An Fan / BinBin Liu / Ying Zhang / YaLing Hu / YaNa Zhou / JiaKai Shao / XiaoDong Li / FengMei Lian / XiaoLin Tong

Frontiers in Medicine, Vol

A Randomized Controlled Trial

2021 Volume 8

Abstract: Objective: To conduct a randomized controlled clinical trial to evaluate the clinical efficacy and prognostic value of Jinhua Qinggan granules in patients with confirmed and suspected coronavirus disease 2019 (COVID-19).Methods: A total of 123 suspected ... ...

Abstract	Objective: To conduct a randomized controlled clinical trial to evaluate the clinical efficacy and prognostic value of Jinhua Qinggan granules in patients with confirmed and suspected coronavirus disease 2019 (COVID-19).Methods: A total of 123 suspected and confirmed COVID-19 patients participated in this clinical trial and were randomly divided into Jinhua and Western medicine groups. For 14 days, the Jinhua group was treated with Jinhua Qinggan granules and antiviral drugs, and the Western medicine group was treated with antiviral drugs alone. We collected information on clinical symptoms, disease aggravation rates, and negative conversion rates of nucleic acids in patients, and observed the effects of anti-infective drugs.Results: There was no significant difference in symptom improvement rates between the two groups, both confirmed and suspected patients (P > 0.05). Both treatments relieved symptoms such as fever, fatigue, and diarrhea. However, the Jinhua treatment was superior in relieving fever and poor appetite. Anti-infective drug use rates were significantly lower in the Jinhua group than in the control group.Conclusion: Jinhua Qinggan granules combined with Western medicine could relieve the clinical symptoms of fever and poor appetite in COVID-19 patients, reduce the use of antibiotics to a certain extent.Clinical Trial Registration: The registration number at China Clinical Trial Registry is ChiCTR2000029601.
Keywords	Jinhua Qinggan granules ; COVID-19 ; randomized controlled trial ; Chinese medicinal ; treatment ; Medicine (General) ; R5-920
Subject code	610
Language	English
Publishing date	2021-10-01T00:00:00Z
Publisher	Frontiers Media S.A.
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Long-term effect of Chinese herbal medicine Tianqi Capsule on the incidence of diabetes

Bing Pang / Chun-Yong Han / Qing-Hu He / Jing Liu / Qing-Wei Li / Yu-Jiao Zheng / Feng-Mei Lian / Xiao-Lin Tong

Traditional Medicine Research, Vol 3, Iss 4, Pp 166-

an 8-year cohort study protocol

2018 Volume 172

Abstract: Background: The rapid growth of type 2 diabetes mellitus (T2DM) remains a big challenge for clinicians worldwide. Traditional Chinese medicine may bring a new approach for solving this problem. The Tianqi Capsule Diabetes Prevention Study (REDUCES Study) ...

Abstract	Background: The rapid growth of type 2 diabetes mellitus (T2DM) remains a big challenge for clinicians worldwide. Traditional Chinese medicine may bring a new approach for solving this problem. The Tianqi Capsule Diabetes Prevention Study (REDUCES Study) reported that 1 years of therapy with Tianqi capsule reduced the risk of diabetes by 32.1% compared with the placebo. Here we aimed to assess the long-term effect of Tianqi capsule on prevention of T2DM in people with impaired glucose tolerance after discontinuation of active intervention. Methods/design: 420 subjects will be followed-up for 8 years to assess the long-term effect of Tianqi capsule intervention. The causes of death and the status of living subjects will be investigated. Follow-up data for living subjects will be collected by personal interview and clinical examination and medical record review to determine diabetes status. Questionnaires will be given to all the subjects to investigate the factors that probably affect the diabetes status during the 8-year of discontinuation of intervention. The primary outcome is the incidence of T2DM, and the secondary outcomes are body mass index, blood glucose, blood lipids and blood pressure. The Cox proportional hazards model will be used to estimate the hazard ratio for diabetes incidence. Analyses will be done with SAS 8.2 software package. Discussion: Results from this study may provide evidence for the long-term efficacy of Tianqi capsule in patients with prediabetes. The findings will provide a basis for further confirmatory studies. Ethics: The protocol has been approved by the Medical Ethics Committee of Guang’anmen Hospital of China Academy of Chinese Medical Sciences (approval number 2016-046-KY-01). Study registration number: ClinicalTrials.gov; NCT02848053.
Keywords	Long-term effect ; Diabetes ; Prevention ; Tianqi capsule ; Medicine ; R ; Miscellaneous systems and treatments ; RZ409.7-999
Language	English
Publishing date	2018-07-01T00:00:00Z
Publisher	Hong Kong Gold Orchid Science and Technology Co., Limited
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Chinese herbal medicine TangBi Formula treatment of patients with type 2 diabetic distal symmetric polyneuropathy disease

De Jin / Wen-jing Huang / Xiang Meng / Fan Yang / Yu-jiao Zheng / Qi Bao / Mei-zhen Zhang / Ya-nan Yang / Qing Ni / Feng-mei Lian / Xiao-lin Tong

Trials, Vol 18, Iss 1, Pp 1-

study protocol for a randomized controlled trial

2017 Volume 10

Abstract: Abstract Background Diabetic distal symmetric polyneuropathy (DSPN) is one of the most common microvascular complications of diabetes mellitus, and it has become a major public health problem worldwide because of its high and increasing prevalence, ... ...

Abstract	Abstract Background Diabetic distal symmetric polyneuropathy (DSPN) is one of the most common microvascular complications of diabetes mellitus, and it has become a major public health problem worldwide because of its high and increasing prevalence, morbidity, and disability rate. The current medications for DSPN are not entirely satisfactory. Preliminary studies indicated that the Chinese herbal TangBi Formula may alleviate signs and symptoms and improve the velocity of nerve conduction in patients with DSPN. This study was designed to determine if Chinese herbal medicine used in combination with conventional treatment is more effective than conventional treatment alone. Methods/design We are conducting a multicenter, placebo-controlled, double-blind, randomized, controlled clinical trial as a means of assessing the therapeutic effects of traditional Chinese medicine (TCM) treatment. A total of 188 patients will be randomized in a 1:1 ratio to a treatment group (TangBi Formula plus mecobalamin) and a control group (placebo plus mecobalamin). The test period lasts 6 months, during which all of the patients will be given standard medical care as recommended by established guidelines. The primary outcome will be development of differences in changes in clinical symptoms and signs in patients and changes in Michigan Diabetic Neuropathy Score (MDNS) between the two groups before and after treatment. The secondary outcome will be changes in nerve conduction velocity and in single clinical signs and symptoms. Safety assessments and adverse events will also be evaluated. Discussion We postulate that patients with DSPN will benefit from therapy that includes TCM. If successful, this work will provide an evidence-based complementary therapeutic approach for treatment of DSPN. Trial registration ClinicalTrials.gov, NCT03010241 . Registered on 2 January 2017
Keywords	Diabetic distal symmetric polyneuropathy ; Traditional Chinese medicine ; Treatment ; Clinical trials ; Medicine (General) ; R5-920
Subject code	610
Language	English
Publishing date	2017-12-01T00:00:00Z
Publisher	BMC
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in Prediabetes

Xi Li / Feng-Mei Lian / Dong Guo / Lan Fan / Jie Tang / Jing-Bo Peng / Hong-Wen Deng / Zhao-Qian Liu / Xin-Hua Xiao / Yan-Rong Wang / Ke-Yi Qu / Sheng Deng / Qi Zhong / Yi-Ling Sha / Yan Zhu / Yu-Jing Bai / Xin-Yan Chen / Qiang Zhou / Hong-Hao Zhou /

Xiao-Lin Tong / Wei Zhang

Evidence-Based Complementary and Alternative Medicine, Vol

2013 Volume 2013

Abstract: Therapeutic interventions in prediabetes are important in the primary prevention of type 2 diabetes (T2D) and its chronic complications. However, little is known about the pharmacogenetic effect of traditional herbs on prediabetes treatment. A total of ... ...

Abstract	Therapeutic interventions in prediabetes are important in the primary prevention of type 2 diabetes (T2D) and its chronic complications. However, little is known about the pharmacogenetic effect of traditional herbs on prediabetes treatment. A total of 194 impaired glucose tolerance (IGT) subjects were treated with traditional hypoglycemic herbs (Tianqi Jiangtang) for 12 months in this study. DNA samples were genotyped for 184 mutations in 34 genes involved in drug metabolism or transportation. Multinomial logistic regression analysis indicated that rs1142345 (A>G) in the thiopurine S-methyltransferase (TPMT) gene was significantly associated with the hypoglycemic effect of the drug (P=0.001, FDR P=0.043). The “G” allele frequencies of rs1142345 in the healthy (subjects reverted from IGT to normal glucose tolerance), maintenance (subjects still had IGT), and deterioration (subjects progressed from IGT to T2D) groups were 0.094, 0.214, and 0.542, respectively. Binary logistic regression analysis indicated that rs1142345 was also significantly associated with the hypoglycemic effect of the drug between the healthy and maintenance groups (P=0.027, OR=4.828) and between the healthy and deterioration groups (P=0.001, OR=7.811). Therefore, rs1142345 was associated with the clinical effect of traditional hypoglycemic herbs. Results also suggested that TPMT was probably involved in the pharmacological mechanisms of T2D.
Keywords	Other systems of medicine ; RZ201-999
Subject code	150
Language	English
Publishing date	2013-01-01T00:00:00Z
Publisher	Hindawi Limited
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: World Congress Integrative Medicine & Health 2017

Carolyn Ee / Sharmala Thuraisingam / Marie Pirotta / Simon French / Charlie Xue / Helena Teede / Agnete E. Kristoffersen / Fuschia Sirois / Trine Stub / Jennifer Engler / Stefanie Joos / Corina Güthlin / Jennifer Felenda / Christiane Beckmann / Florian Stintzing / Roni Evans / Gert Bronfort / Daniel Keefe / Anna Taberko /

Linda Hanson / Alex Haley / Haiwei Ma / Joseph Jolton / Lana Yarosh / Francis Keefe / Jung Nam / Liwanag Ojala / Mary J. Kreitzer / Careen Fink / Karin Kraft / Andrew Flower / George Lewith / Kim Harman / Beth Stuart / Felicity L. Bishop / Jane Frawley / Lilla Füleki / Eva Kiss / Tamas Vancsik / Tibor Krenacs / Martha Funabashi / Katherine A. Pohlman / Silvano Mior / Haymo Thiel / Michael D. Hill / David J. Cassidy / Michael Westaway / Jerome Yager / Eric Hurwitz / Gregory N. Kawchuk / Maeve O’Beirne / Sunita Vohra / Isabelle Gaboury / Chantal Morin / Katharina Gaertner / Loredana Torchetti / Martin Frei-Erb / Michael Kundi / Michael Frass / Eugenia Gallo / Valentina Maggini / Mattia Comite / Francesco Sofi / Sonia Baccetti / Alfredo Vannacci / Mariella Di Stefano / Maria V. Monechi / Luigi Gori / Elio Rossi / Fabio Firenzuoli / Rocco D. Mediati / Giovanna Ballerini / Paula Gardiner / Anna S. Lestoquoy / Lily Negash / Sarah Stillman / Prachi Shah / Jane Liebschutz / Pamela Adelstein / Christine Farrell-Riley / Ivy Brackup / Brian Penti / Robert Saper / Isabel Giralt Sampedro / Gilda Carvajal / Andreas Gleiss / Marie M. Gross / Dorothea Brendlin / Jonas Röttger / Wiebke Stritter / Georg Seifert / Noelle Grzanna / Rainer Stange / Peter W. Guendling / Wen Gu / Yan Lu / Jie Wang / Chengcheng Zhang / Hua Bai / Yuxi He / Xiaoxu Zhang / Zhengju Zhang / Dali Wang / Fengxian Meng / Alexander Hagel / Heinz Albrecht / Claudia Vollbracht / Wolfgang Dauth / Wolfgang Hagel / Francesco Vitali / Ingo Ganzleben / Hans Schultis / Peter Konturek / Jürgen Stein / Markus Neurath / Martin Raithel / Bianka Krick / Heidemarie Haller / Petra Klose / Gustav Dobos / Sherko Kümmel / Holger Cramer / Felix J. Saha / Anna Kowoll / Barbara Ebner / Bettina Berger / Kyung-Eun Choi / Lisha He / Han Wang / X. He / C. Gu / Y. Zhang / Linhua Zhao / Xiaolin Tong / Xinhui He / Chengjuan Gu / Ying Zhang / Robin S. T. Ho / Vincent C. H. Chung / Xinyin Wu / Charlene H. L. Wong / Justin C. Y. Wu / Samuel Y. S. Wong / Alexander Y. L. Lau / Regina W. S. Sit / Wendy Wong / Michelle Holmes / Felicity Bishop / Lynn Calman / Dave Newell / Jonathan Field / Win L. Htut / Dongwoon Han / Da I. Choi / Soo J. Choi / Ha Y. Kim / Jung H. Hwang / Ching W. Huang / Bo H. Jang / Fang P. Chen / Seong G. Ko / Wenjing Huang / De Jin / Fengmei Lian / Soobin Jang / Kyeong H. Kim / Eun K. Lee / Seung H. Sun / Ho Y. Go / Youme Ko / Sunju Park / Yong C. Shin / Hubert Janik / Natalie Greiffenhagen / Jürgen Bolte / Mariusz Jaworski / Miroslawa Adamus / Aleksandra Dobrzynska / Michael Jeitler / Jessica Jaspers / Christel von Scheidt / Barbara Koch / Andreas Michalsen / Nico Steckhan / Christian Kessler / Wen-jing Huang / Bing Pang / Feng-Mei Lian / Miek Jong / Erik Baars / Anja Glockmann / Harald Hamre / Mosaburo Kainuma / Aya Murakami / Toshio Kubota / Daisuke Kobayashi / Yasuhiro Sumoto / Norihiro Furusyo / Shin-Ichi Ando / Takao Shimazoe / Olaf Kelber / S. Verjee / Eva Gorgus / Dieter Schrenk / Kathi Kemper / Ellie Hill / Nisha Rao / Gregg Gascon / John Mahan / Gunver Kienle / Jörg Dietrich / Claudia Schmoor / Roman Huber / Weon H. Kim / Mansoor Ahmed / Luzhu He / Jung Hye Hwang / Nora Meggyeshazi / Csaba Kovago / Anne K. Klaus / Roland Zerm / Danilo Pranga / Thomas Ostermann / Marcus Reif / Hans Broder von Laue / Benno Brinkhaus / Matthias Kröz / Daniela Rodrigues Recchia / Hans B. von Laue / Christien T. Klein-Laansma / Mats Jong / Cornelia von Hagens / Jean P. Jansen / Herman van Wietmarschen / Miek C. Jong / Seung-Ho Sun / Ho-Yeon Go / Chan-Yong Jeon / Yun-Kyung Song / Seong-Gyu Ko / Anna K. Koch / Sybille Rabsilber / Romy Lauche / Jost Langhorst / Milena Trifunovic-Koenig / Evi Koster / Diana Delnoij / Lena Kroll / Kathrin Weiss / Ai Kubo / Sarah Hendlish / Andrea Altschuler / Nancy Connolly / Andy Avins / Jon Wardle / David Lee / David Sibbritt / Jon Adams / Crystal Park / Gita Mishra / Johann Lechner / Inseon Lee / Younbyoung Chae / Jisu Lee / Seung H. Cho / Yujin Choi / Jee Y. Lee / Han S. Ryu / Sung S. Yoon / Hye K. Oh / Lyun K. Hyun / Jin O. Kim / Seong W. Yoon / Ju-Yeon Lee / Sang-Hoon Shin / Min Jang / Indra Müller / So-Hyun Janson Park / Lance Laird / Suzanne Mitchell / Xiaofei Li / Yunhui Wang / Jianhua Zhen / He Yu / Tiegang Liu / Xiaohong Gu / Hui Liu / Weiguo Ma / Xuezheng Shang / Yu Bai / Wei Liu / Collin Rooney / Amos Smith / Shirlene Lopes / Marcelo Demarzo / Maria do Patrocínio Nunes / Peter Lorenz / Carsten Gründemann / Miriam Heinrich / Manuel Garcia-Käufer / Franziska Grunewald / Silke Messerschmidt / Anja Herrick / Kim Gruber / Matthias Knödler / Carmen Steinborn / Taoying Lu / Lixin Wang / Darong Wu / Christina M Luberto / Daniel L. Hall / Emma Chad-Friedman / Suzanne Lechner / Elyse R. Park / Christina M. Luberto / Elyse Park / Janice Goodman / Sonja Luer / Matthias Heri / Klaus von Ammon / Ida Landini / Andrea Lapucci / Stefania Nobili / Enrico Mini / Clare McDermott / Selwyn Richards / Diane Cox / Sarah Frossell / Geraldine Leydon / Caroline Eyles / Hilly Raphael / Rachael Rogers / Michelle Selby / Charlotte Adler / Jo Allam / Xiangwei Bu / Honghong Zhang / Jianpeng Zhang / Michael Mikolasek / Jonas Berg / Claudia Witt / Jürgen Barth / Ivan Miskulin / Zdenka Lalic / Maja Miskulin / Albina Dumic / Damir Sebo / Aleksandar Vcev / Nasr A. A. Mohammed / Soo Jeung Choi / Hyea Bin Im / Anwesha Mukherjee / Amit Kandhare / Subhash Bodhankar / Prasad Thakurdesai / Niki Munk / Erica Evans / Amanda Froman / Matthew Kline / Matthew J. Bair / Frauke Musial / Terje Alræk / Harald J. Hamre / Lars Björkman / Vinjar M. Fønnebø / Feng-mei Lian / Qing Ni / Xiao-lin Tong / Xin-long Li / Wen-ke Liu / Shuo Feng / Xi-yan Zhao / Yu-jiao Zheng / Xue-min Zhao / Yi-qun Lin / Tian-yu Zhao / Xi-Yan Zhao / Hui Che Phd / Chen Zhang / Feng Liu / Lin-hua Zhao / Ru Ye / Cheng-juan Gu / Wenbo Peng / Diana De Carvalho / Mohamed El-Bayoumi / Bob Haig / Kimbalin Kelly / Darrell J. Wade / Emanuela Portalupi / Giampietro Gobo / Luigi Bellavita / Chiara Guglielmetti / Christa Raak / Myriam Teuber / Friedrich Molsberger / Ulrich von Rath / Ulrike Reichelt / Uta Schwanebeck / Sabine Zeil / Christian Vogelberg / Dolores Rodríguez Veintimilla / Guerrero Tapia Mery / Marisol Maldonado Villavicencio / Sandra Herrera Moran / Christian Sachse / Peter W Gündlin / Monirsadat Sahebkarkhorasani / Hoda Azizi / Dania Schumann / Tobias Sundberg / Matthew J. Leach / Susana Seca / Henry Greten / Sugir Selliah / Anu Shakya / Ha Yun Kim / Hyea B. Im / Anna Sherbakova / Gudrun Ulrich-Merzenich / Heba Abdel-Aziz / Erica Sibinga / Lindsey Webb / Jonathan Ellen / Kari Skrautvol / Dagfinn Nåden / Rhayun Song / Weronika Grabowska / Kamila Osypiuk / Gloria V. Diaz / Paolo Bonato / Moonkyoung Park / Jeffrey Hausdorff / Michael Fox / Lewis R. Sudarsky / Daniel Tarsy / James Novakowski / Eric A. Macklin / Peter M. Wayne / Inok Hwang / Sukhee Ahn / Myung-Ah Lee / Min K. Sohn / Oleg Sorokin / Dagmar Heydeck / Astrid Borchert / Christoph-Daniel Hohmann / Harmut Kühn / Clemens Kirschbaum / Tobias Stalder / Barbara Stöckigt / Michael Teut / Ralf Suhr / Daniela Sulmann / Chris Streeter / Patrica Gerbarg / Marisa Silveri / Richard Brown / John Jensen / Britta Rutert / Angelika Eggert / Alfred Längler / Christine Holmberg / Jin Sun / Xin Deng / Wen-Yuan Li / Bin Wen / Nicola Robinson / Jian-Ping Liu / Hyun K. Sung / Narae Yang / Seon M. Shin / Hee Jung / Young J. Kim / Woo S. Jung / Tae Y. Park / Kiyoshi Suzuki / Toshinori Ito / Seiya Uchida / Seika Kamohara / Naoya Ono / Mitsuyuki Takamura / Ayumu Yokochi / Kazuo Maruyama / Patricio Tapia / Katarzyna Thabaut / Anja Thronicke / Megan Steele / Harald Matthes / Cornelia Herbstreit / Friedemann Schad / Jiaxing Tian / Libo Yang / Tian Tian / Hewei Zhang / Xia Tian / CongCong Wang / Qian Yun Chai / Lijuan Zhang / Ruyu Xia / Na Huang / Yutong Fei / Jianpin Liu / Natalie Trent / Mindy Miraglia / Jeffrey Dusek / Edi Pasalis / Sat B. Khalsa / Milena Trifunovic-König / Anna Koch / Lisa Uebelacker / Geoffrey Tremont / Lee Gillette / Gary Epstein-Lubow / David Strong / Ana Abrantes / Audrey Tyrka / Tanya Tran / Brandon Gaudiano / Ivan Miller / Gerhild Ullmann / Yuhua Li / Sujata Vaidya / Vinod Marathe / Ana C. Vale / Jacquelyne Motta / Fabíola Donadão / Angela C. Valente / Luana C. Carvalho Valente / Ricardo Ghelman / Dusan Vesovic / Dragan Jevdic / Aleksandar Jevdic / Katarina Jevdic / Mihael Djacic / Dragica Letic / Drago Bozic / Marija Markovic / Slobodan Dunjic / Gordana Ruscuklic / Dezire Baksa / Kenan Vrca / Ann Vincent / Dietlind Wahner-Roedler / Mary Whipple / Maria M. Vogelius / Iris Friesecke / Peter W. Gündling / Saswati Mahapatra / Rebecca Hynes / Kimberly Van Rooy / Sherry Looker / Aditya Ghosh / Brent Bauer / Susanne Cutshall / Harald Walach / Ana Borges Flores / Michael Ofner / Andreas Kastner / Gerhard Schwarzl / Hermann Schwameder / Nathalie Alexander / Gerda Strutzenberger / Xianwei Bu / Jianping Zhang / Shang Wang / Jinfeng Shi / Yu Hao / Jun Wu / Zeji Qiu / Yuh-Hai Wang / Chi-Jung Lou / Sam Watts / Peter Wayne / Gloria Vergara-Diaz / Brian Gow / Jose Miranda / Lewis Sudarsky / Eric Macklin / Kathrin Wode / Jenny Bergqvist / Britt-Marie Bernhardsson / Johanna Hök Nordberg / Lena Sharp / Roger Henriksson / Yeonju Woo / Min K. Hyun / Hao Wu / Tian-Fang Wang / Yan Zhao / Yu Wei / Lei Tian / Lei He / Xue Wang / Ruohan Wu / Mei Han / Patrina H. Y. Caldwell / Shigang Liu / Jing Zhang / Jianping Liu / Qianyun Chai / Zhongning Guo / Congcong Wang / Zhijun Liu / Xun Li / I. J. Yang / V. Ruberio Lincha / S. H. Ahn / D. U. Lee / H. M. Shin / Lu Yang / N. Yang / H. Sung / S. M. Shin / H. Y. Go / H. Jung / Y. Kim / T. Y. Park / Angela Yap / Yu H. Kwan / Chuen S. Tan / Syed Ibrahim / Seng B. Ang / Alfred Yayi / Jeong E. Yoo / Ho R. Yoo / Sae B. Jang / Hye L. Lee / Ala’a Youssef / Shahira Ezzat / Amira Abdel Motaal / Hesham El-Askary / Xiaotong Yu / Yashan Cui / Younghee Yun / Jin-Hyang Ahn / Bo-Hyung Jang / Kyu-Seok Kim / Inhwa Choi / Augustina Glinz / Fadime ten Brink / Arnd Büssing / Christoph Gutenbrunner / Bert Helbrecht / Tiesheng Fang / Fengxion Meng / Zhiming Shen / Ruixin Zhang / Fan Wu / Ming Li / Xinyun Xuan / Xueyong Shen / Ke Ren / Brian Berman / Zian Zheng / Yuxiang Wan / Xueyan Ma / Fei Dong / Suzie Zick / Richard Harris / Go E. Bae / Jung N. Kwon / Hye Y. Lee / Jong K. Nam / Sang D. Lee / Dong H. Lee / Ji Y. Han / Young J. Yun / Ji H. Lee / Hye L. Park / Seong H. Park / Chiara Bocci / Giovanni B. Ivaldi / Ilaria Vietti / Ilaria Meaglia / Marta Guffi / Rubina Ruggiero / Marita Gualea / Emanuela Longa / Massimo Bonucci / Sarah Croke / Lourdes Diaz Rodriguez / Juan C. Caracuel-Martínez / Manuel F. Fajardo-Rodríguez / Angélica Ariza-García / Francisca García-De la Fuente / Manuel Arroyo-Morales / Maria S. Estrems / Vicente G. Gómez / Mónica Valero Sabater / Rosaria Ferreri / Simonetta Bernardini / Roberto Pulcri / Franco Cracolici / Massimo Rinaldi / Claudio Porciani / Peter Fisher / John Hughes / Ariadna Mendoza / Hugh MacPherson / Jacqueline Filshie / Antonia Di Francesco / Alberto Bernardini / Monica Messe / Vincenzo Primitivo / Piera A. Iasella / Monica Taminato / Jaqueline Do Carmo Alcantara / Katia R. De Oliveira / Debora C. De Azevedo Rodrigues / Juliana R. Campana Mumme / Olga K. Matsumoto Sunakozawa / Vicente Odone Filho / Joshua Goldenberg / Andrew Day / Masa Sasagawa / Lesley Ward / Kieran Cooley / Thora Gunnarsdottir / Ingibjorg Hjaltadottir / Mahdie Hajimonfarednejad / Nicole Hannan / Rut Hellsing / Susanne Andermo / Maria Arman / Iris von Hörsten / Patricia Vásquez Torrielo / Carmen L. Andrade Vilaró / Francisco Cerda Cabrera / Henny Hui / Eric Ziea / Dora Tsui / Joyce Hsieh / Christine Lam / Edith Chan / Mark P. Jensen / Samuel L. Battalio / Joy Chan / Karlyn A. Edwards / Kevin J. Gertz / Melissa A. Day / Leslie H. Sherlin / Dawn M. Ehde / Bo-Hyoung Jang / Anja Börner / Jihong Lee / Boram Lee / Gyu T. Chang / Alejandra Menassa / Yoshiharu Motoo / Jürgen Müller / Sabine Rabini / Bettina Vinson / Martin Storr / Martin Niemeijer / Joop Hoekman / Wied Ruijssenaaars / Faith C. Njoku / Arne J. Norheim / Filiz Okumus / Halime Oncu-Celik

BMC Complementary and Alternative Medicine, Vol 17, Iss S1, Pp 1-

part two

2017 Volume 65

Keywords	Other systems of medicine ; RZ201-999
Language	English
Publishing date	2017-06-01T00:00:00Z
Publisher	BMC
Document type	Article ; Online
Database	BASE - Bielefeld Academic Search Engine (life sciences selection)

Full text online

Full text

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

To top

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED

Full text online

More links

Kategorien

Inter-library loan at ZB MED